Evaluation of the Frequency of Non-Alcoholic Fatty Liver Disease Among Coronary Heart Disease Patients

Document Type : Original Article

Authors

1 Lecture of Hepatology, Gastroenterology & infectious diseases Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

2 Professor of Hepatology, Gastroenterology & infectious diseases Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

3 Professor of Cardiology Department, Faculty of Medicine, Zagazig university, zagazig, Egypt

4 Hepatology, Gastroenterology & infectious diseases Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease and cardiovascular complications account for about 40% of total deaths in NAFLD. Evaluation of the link between NAFLD and ischaemic heart disease helps in better management of NAFLD patients and reduction of coronary heart disease complication. this study targets detection of the link between NAFLD and coronary heart diseases, also provides better management of non-alcoholic fatty liver disease patients and helps reduction of cardiovascular complications in these patients. Methods: 84 patients with coronary heart disease were evaluated with routine investigation (CBC, liver function tests, ESR. Lipid profile), BMI, abdominal ultrasound, echocardiography with estimation of wall motion score index of left ventricle, and fib 4 evaluation of liver fibrosis. Results: The severity of cardiac hypokinesia and liver fibrosis were directly proportionate to the severity of liver steatosis. Conclusion: NAFLD is commonly associated with coronary heart disease and the severity of NAFLD detected by ultrasonography is strongly related to the severity of coronary arteries obstruction

Keywords

Main Subjects